Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This drug is a combination of two active pharmaceutical ingredients used primarily for dermatological conditions: - **Betamethasone valerate** is a medium-potency synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. It acts by modulating gene expression to suppress the immune response and reduce inflammation in the skin. Betamethasone valerate is commonly used topically to treat various inflammatory skin disorders such as eczema, psoriasis, and dermatitis[3][4][6][8]. - **Diaminodiphenylsulfone (dapsone)** is a sulfone antibiotic with anti-inflammatory and immunosuppressive effects. It inhibits folic acid synthesis in susceptible organisms (notably Mycobacterium leprae) and has been widely used for leprosy, dermatitis herpetiformis, acne vulgaris, and other skin conditions characterized by neutrophilic infiltration[1]. Dapsone also exhibits antibacterial activity. The combination of these agents may be considered for certain chronic or refractory inflammatory dermatoses where both immunosuppression/anti-inflammation (from betamethasone) and antimicrobial/anti-neutrophilic action (from dapsone) are desired.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on betamethasone valerate + diaminodiphenylsulfone.